MedTrace Logo

Quantification of CD163 Inflammatory Biomarker in Chronic Periodontitis and Diabetic Subjects

NCT03727035 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-10-18

No results posted yet for this study

Summary

The quantification of CD163 will be analysed in the subgingival plaque samples of generalized chronic periodontitis patients with and without diabetes mellitus. The demographic and the periodontal parameters were assessed and the correlated with the quantification of the CD163. The CD163 gene expression was analyzed with RT-PCR and the quantification of CD163 will be done using ELISA.

Conditions

  • Periodontal Diseases

Sponsors & Collaborators

  • Meenakshi Ammal Dental College and Hospital

    lead OTHER

Principal Investigators

  • Jaideep Mahendra, MDS,PhD · Meenakshi Ammal Dental College

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-10
Primary Completion
2019-11-30
Completion
2019-12-15

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03727035 on ClinicalTrials.gov